Cite Filings / LENZ / 0001193125-24-071353
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

LENZ Therapeutics, Inc. · Filed 2024-03-19 · Acc 0001193125-24-071353

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , d780027d8k.htm

Around this filing

  • 2024-03-25 4 Options or other derivatives
  • 2024-03-25 4 Options or other derivatives
  • 2024-03-25 4 Options or other derivatives
  • 2024-03-25 4 10% owner acquired 598,203 shares (other)
  • 2024-03-22 8-K Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Regulation FD disclosure
  • 2024-03-19 8-K Regulation FD disclosure
  • 2024-03-14 8-K Shareholder vote results

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading d780027d8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…